Ovid Therapeutics

Jul 24, 2021

Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

Jan 18, 2021

Angelman Syndrome Market: Insights Into The Recent Late-Stage Drug Failures And Novel Approaches To Treating This Rare Neurogenetic Disorder

Jan 01, 2020

Angelman syndrome: A Rare Genetic Disorder

Dec 13, 2019

Fragile X Syndrome Market

Feb 02, 2017

ALCMI, ALCF and Scancell partner; Sun unloads Ohm Labs plants; Takeda and Ovid join; Guardant and MD Anderson collaborate; Glooko and Ascensia integrate

Newsletter/Whitepaper